G L PHARMA GMBH has a total of 43 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are DELTA-FLY PHARMA INC, NIPPON BIOLOG INC and BIONICHE UROLOGY IP INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 3 | |
#4 | Brazil | 3 | |
#5 | Canada | 3 | |
#6 | Chile | 3 | |
#7 | China | 3 | |
#8 | Mexico | 3 | |
#9 | United States | 3 | |
#10 | Argentina | 1 | |
#11 | Austria | 1 | |
#12 | Hungary | 1 | |
#13 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Wagner Harald | 32 |
#2 | Lechner Doris | 28 |
#3 | Wachter Christof | 28 |
#4 | Winkler Heimo | 26 |
#5 | Huber Daniela | 22 |
#6 | Greimel Katrin | 22 |
#7 | Brandauer Martin | 22 |
#8 | Kroutil Wolfgang | 22 |
#9 | Bleymaier Klaus | 22 |
#10 | Gübitz Georg | 13 |
Publication | Filing date | Title |
---|---|---|
EP3210630A1 | Abuse-deterrent pharmaceutical compositions | |
EP3231420A1 | Abuse-deterrent pharmaceutical compositions | |
EP3210596A1 | Abuse-deterrent pharmaceutical composition | |
HUE040694T2 | Stabilized formulation of a folic acid/iron preparation | |
EP3199167A1 | Medicament for the treatment of iron deficiencies with folic acid deficit | |
TW201700095A | Oral dosage form with delayed release comprising morphine and naloxone | |
WO2015089530A1 | Extended-release oral dosage form containing morphine and naloxone | |
EP2942054A1 | Slow-release pharmaceutical formulation | |
AT511581A1 | Oral retardant formulation |